The DOI matches its Crossref record; 383 of the 388 references it cites were found in a registry or an index.
Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host
Open accessAbstract
Infection and inflammation induce the acute-phase response (APR), leading to multiple alterations in lipid and lipoprotein metabolism. Plasma triglyceride levels increase from increased VLDL secretion as a result of adipose tissue lipolysis, increased de novo hepatic fatty acid synthesis, and suppression of fatty acid oxidation. With more severe infection, VLDL clearance decreases secondary to decreased lipoprotein lipase and apolipoprotein E in VLDL. In rodents, hypercholesterolemia occurs attributable to increased hepatic cholesterol synthesis and decreased LDL clearance, conversion of cholesterol to bile acids, and secretion of cholesterol into the bile. Marked alterations in proteins important in HDL metabolism lead to decreased reverse cholesterol transport and increased cholesterol delivery to immune cells. Oxidation of LDL and VLDL increases, whereas HDL becomes a proinflammatory molecule. Lipoproteins become enriched in ceramide, glucosylceramide, and sphingomyelin, enhancing uptake by macrophages. Thus, many of the changes in lipoproteins are proatherogenic. The molecular mechanisms underlying the decrease in many of the proteins during the APR involve coordinated decreases in several nuclear hormone receptors, including peroxisome proliferator-activated receptor, liver X receptor, farnesoid X receptor, and retinoid X receptor. APR-induced alterations initially protect the host from the harmful effects of bacteria, viruses, and parasites. However, if prolonged, these changes in the structure and function of lipoproteins will contribute to atherogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Decreases in HDL and LDL cholesterol, as well as RCT, belong to the metabolic adaptations found in APR during inflammatory attack67.”
From Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses (2016) · cites this paper as [67]
In the citing paper
“Many acute conditions, including surgical trauma, myocardial infarction and inflammation, induce the systemic acute phase reaction (APR), with acute phase protein production in the liver as an integral part of the host defence response.”
From Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses (2016) · cites this paper as [67]
In the citing paper
“In addition to changes in protein synthesis, also lipid metabolism undergoes significant modifications in APR6667.”
From Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses (2016) · cites this paper as [67]
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 4,694
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,165
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
Research works printed but not linked: 1
- Meng, 2001, Cancer Res., 61, 2250
Cited by
Sorted by citations
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
The immunology of atherosclerosis
Gisterå, A., & Hansson, G. K. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.51 · Cited by 982
Kontush, A., & Chapman, M. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.1 · Cited by 647
Cancello, R., Tordjman, J., Poitou, C., Guilhem, G., Bouillot, J. L., Hugol, D., Coussieu, C., Basdevant, A., Hen, A. B., Bedossa, P., et al. (2006) · Diabetes · doi:10.2337/db06-0133 · Cited by 607
Large-Scale Multi-omic Analysis of COVID-19 Severity
Overmyer, K. A., Shishkova, E., Miller, I. J., Balnis, J., Bernstein, M. N., Peters-Clarke, T. M., Meyer, J. G., Quan, Q., Muehlbauer, L. K., Trujillo, E. A., et al. (2020) · Cell Systems · doi:10.1016/j.cels.2020.10.003 · Cited by 607
Longitudinal multi-omics of host–microbe dynamics in prediabetes
Zhou, W., Sailani, M. R., Contrepois, K., Zhou, Y., Ahadi, S., Leopold, S. R., Zhang, M. J., Rao, V., Avina, M., Mishra, T., et al. (2019) · Nature · doi:10.1038/s41586-019-1236-x · Cited by 583
Hoffman, H. M., Throne, M. L., Amar, N. J., Sebai, M., Kivitz, A. J., Kavanaugh, A., Weinstein, S. P., Belomestnov, P., Yancopoulos, G. D., Stahl, N., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23687 · Cited by 577
Magnesium and the Inflammatory Response: Potential Physiopathological Implications
Mazur, A., Maier, J. A. M., Rock, E., Gueux, E., Nowacki, W., & Rayssiguier, Y. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.03.031 · Cited by 474
Infection, inflammation, height, and longevity
Crimmins, E. M., & Finch, C. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501470103 · Cited by 468
The Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases
Brown, J. M., & Hazen, S. L. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-060513-093205 · Cited by 438
Unraveling the complexities of the HDL lipidome
Kontush, A., Lhomme, M., & Chapman, M. J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036095 · Cited by 409
Energy regulation and neuroendocrine–immune control in chronic inflammatory diseases
Straub, R. H., Cutolo, M., Buttgereit, F., & Pongratz, G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02218.x · Cited by 382
The role of Interleukin 6 in the pathophysiology of rheumatoid arthritis
Srirangan, S., & Choy, E. (2010) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x10378372 · Cited by 371
HDL-targeted therapies: progress, failures and future
Kingwell, B. A., Chapman, M. J., Kontush, A., & Miller, N. E. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4279 · Cited by 354
Antiatherogenic small, dense HDL—guardian angel of the arterial wall?
Kontush, A., & Chapman, M. J. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0500 · Cited by 355
Metabolic stress and inflammatory response in high-yielding, periparturient dairy cows
Trevisi, E., Amadori, M., Cogrossi, S., Razzuoli, E., & Bertoni, G. (2011) · Research in Veterinary Science · doi:10.1016/j.rvsc.2011.11.008 · Cited by 338
Human Immunodeficiency Virus Impairs Reverse Cholesterol Transport from Macrophages
Mujawar, Z., Rose, H. M., Morrow, M. P., Pushkarsky, T., Dubrovsky, L., Mukhamedova, N., Fu, Y., Dart, A. M., Orenstein, J. M., Bobryshev, Y. V., et al. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040365 · Cited by 335
McInnes, I. B., Thompson, L., Giles, J. T., Bathon, J. M., Salmon, J. E., Beaulieu, A. D., Codding, C. E., Carlson, T. H., Delles, C., Lee, J. S., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204345 · Cited by 336
DiAngelo, J. R., Bland, M. L., Bambina, S., Cherry, S. R., & Birnbaum, M. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906749106 · Cited by 311
The association of periodontal diseases with metabolic syndrome and obesity
Jepsen, S. V., Suvan, J. E., & Deschner, J. (2020) · Periodontology 2000 · doi:10.1111/prd.12326 · Cited by 325
HDL in innate and adaptive immunity
Catapano, A. L., Pirillo, A., Bonacina, F., & Norata, G. D. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu150 · Cited by 301
Choy, E., & Sattar, N. A. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101964 · Cited by 296
van Diepen, J. A., Berbée, J. F. P., Havekes, L. M., & Rensen, P. C. N. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.02.028 · Cited by 297
Beyond Low Plasma T3: Local Thyroid Hormone Metabolism during Inflammation and Infection
Boelen, A., Kwakkel, J., & Fliers, E. (2011) · Endocrine Reviews · doi:10.1210/er.2011-0007 · Cited by 287
Structure of HDL: Particle Subclasses and Molecular Components
Kontush, A., Lindahl, M. G., Lhomme, M., Calabresi, L., Chapman, M. J., & Davidson, W. S. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_1 · Cited by 284
Nibali, L., D’Aiuto, F., Griffiths, G. S., Patel, K., Suvan, J. E., & Tonetti, M. S. (2007) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2007.01133.x · Cited by 279
Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
Dayer, J., & Choy, E. (2009) · Rheumatology · doi:10.1093/rheumatology/kep329 · Cited by 277
Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm
Robertson, J., Peters, M. J. L., McInnes, I. B., & Sattar, N. A. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.91 · Cited by 268
An umbrella review of the evidence linking oral health and systemic noncommunicable diseases
Botelho, J., Mascarenhas, P., Viana, J., Proença, L., Orlandi, M., Leira, Y., Chambrone, L., Mendes, J. J., & Machado, V. (2022) · Nature Communications · doi:10.1038/s41467-022-35337-8 · Cited by 308
KONES, R. J. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s14934 · Cited by 265
Elahi, M. M., Cagampang, F. R. A., Mukhtar, D., Anthony, F. W., Ohri, S. K., & Hanson, M. A. (2009) · British Journal Of Nutrition · doi:10.1017/s000711450820749x · Cited by 259
Mechanisms of triglyceride accumulation in activated macrophages
Feingold, K. R., Shigenaga, J. K., Kazemi, M. R., McDonald, C. M., Patzek, S. M., Cross, A. S., Moser, A. H., & Grünfeld, C. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1111537 · Cited by 257
Self-citationSphingolipid Signaling in Metabolic Disorders
Hla, T., & Dannenberg, A. J. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.017 · Cited by 251
Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome
Fessler, M. B., Rudel, L. L., & Brown, J. M. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832fa5c4 · Cited by 256
Xie, L., Li, J., Xie, L., & Bourne, P. E. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000387 · Cited by 250
Ruiz-Núñez, B., Pruimboom, L., Dijck-Brouwer, D. A. J., & Muskiet, F. A. J. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.02.009 · Cited by 246
The relation of saturated fatty acids with low-grade inflammation and cardiovascular disease
Ruiz-Núñez, B., Dijck-Brouwer, J., & Muskiet, F. A. J. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.12.007 · Cited by 249
Shiri-Sverdlov, R., Wouters, K., Gorp, P. J. V., Gijbels, M. J., Noel, B., Buffat, L., Staels, B., Maeda, N., Bilsen, M. V., & Hofker, M. H. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.033 · Cited by 241
HDL in Infectious Diseases and Sepsis
Pirillo, A., Catapano, A. L., & Norata, G. D. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_15 · Cited by 239
UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis
Moon, J.-S., Lee, S., Park, M.-A., Siempos, I. I., Haslip, M., Lee, P. J., Yun, M., Kim, C. K., Howrylak, J., Ryter, S. W., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78253 · Cited by 238
RetractedFarnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy
Jiang, T., Wang, X. X., Scherzer, P., Wilson, P. V., Tallman, J., Takahashi, H., Li, J., Iwahashi, M., Sutherland, E. M., Arend, L. J., et al. (2007) · Diabetes · doi:10.2337/db06-1642 · Cited by 232
Chait, A., Han, C. Y., Oram, J. F., & Heinecke, J. W. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r400017-jlr200 · Cited by 236
High-Density Lipoprotein and Coronary Heart Disease
Natarajan, P., Ray, K. K., & Cannon, C. P. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.008 · Cited by 231
Inflammation stimulates the expression of PCSK9
Feingold, K. R., Moser, A. H., Shigenaga, J. K., Patzek, S. M., & Grünfeld, C. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.023 · Cited by 228
Self-citationiNOS as a metabolic enzyme under stress conditions
Anavi, S., & Tirosh, O. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.10.411 · Cited by 229
Inflammation, von Willebrand factor, and ADAMTS13
Chen, J., & Chung, D. W. (2018) · Blood · doi:10.1182/blood-2018-02-769000 · Cited by 219
Zheng, H., Wang, J., Wei, X., Chang, L., & Liu, S. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143085 · Cited by 220
Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
Vaisar, T., Tang, C., Babenko, I., Hutchins, P. M., Wimberger, J., Suffredini, A. F., & Heinecke, J. W. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m059089 · Cited by 214
Analytical strategies in lipidomics and applications in disease biomarker discovery
Hu, C., van der Heijden, R., Wang, M., van der Greef, J., Hankemeier, T., & Xu, G. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.01.038 · Cited by 214
Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?
Otocka-Kmiecik, A., Mikhailidis, D. P., Nicholls, S. J., Davidson, M. H., Rysz, J., & Banach, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.03.003 · Cited by 207
Multiple actions of high-density lipoprotein
Florentin, M., Liberopoulos, E. N., Wierzbicki, A. S., & Mikhailidis, D. P. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283043806 · Cited by 200
Serum triglyceride concentrations and cancer risk in a large cohort study in Austria
VHM & PP Study Group, Ulmer, H., Borena, W., Rapp, K., Klenk, J., Strasak, A. M., Diem, G., Concin, H., & Nagel, G. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605264 · Cited by 205
Sphingosine 1-Phosphate Lyase Deficiency Disrupts Lipid Homeostasis in Liver
Bektas, M., Allende, M. L., Lee, B. G., Chen, W., Amar, M. J., Remaley, A. T., Saba, J. D., & Proia, R. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081489 · Cited by 205
Interplay between rumen digestive disorders and diet-induced inflammation in dairy cattle
Zebeli, Q., & Metzler-Zebeli, B. U. (2012) · Research in Veterinary Science · doi:10.1016/j.rvsc.2012.02.004 · Cited by 195
Lipoproteins in inflammation and sepsis. II. Clinical aspects
Wendel, M., Paul, R., & Heller, A. R. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0433-x · Cited by 195
Roles of Infection, Inflammation, and the Immune System in Cholesterol Gallstone Formation
Maurer, K. J., Carey, M. C., & Fox, J. G. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.12.031 · Cited by 195
Emerging role of high density lipoproteins as a player in the immune system
Norata, G. D., Pirillo, A., Ammirati, E., & Catapano, A. L. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.045 · Cited by 195
Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation
Salio, M., Speak, A. O., Shepherd, D., Polzella, P., Illarionov, P. A., Veerapen, N., Besra, G. S., Platt, F. M., & Cerundolo, V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710145104 · Cited by 191
Venteclef, N., Jakobsson, T., Ehrlund, A., Damdimopoulos, A., Mikkonen, L., Ellis, E., Nilsson, L.-M., Parini, P., Jänne, O. A., Gustafsson, J.-Å., et al. (2010) · Genes & Development · doi:10.1101/gad.545110 · Cited by 178
Bilberries reduce low‐grade inflammation in individuals with features of metabolic syndrome
Kolehmainen, M., Mykkänen, O. T., Kirjavainen, P. V., Leppänen, T., Moilanen, E., Adriaens, M. E., Laaksonen, D. E., Hallikainen, M., Puupponen‐Pimiä, R., Pulkkinen, L., et al. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200195 · Cited by 194
Gallbladder disease is associated with insulin resistance in a high risk Hispanic population
Nervi, F. O., Miquel, J. F., Alvarez, M. G., Catterina Ferreccio, R., García‐Zattera, M. J., Gonzalez, R. G., Pérez‐Ayuso, R. M., Rigotti, A., & Villarroel, L. A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.01.026 · Cited by 184
HDL dysfunction in diabetes: causes and possible treatments
Farbstein, D., & Levy, A. P. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.182 · Cited by 178
Serum amyloid A impairs the antiinflammatory properties of HDL
Han, C. Y., Tang, C., Guevara, M. E., Hao, W., Wietecha, T., Shao, B., Subramanian, S., Omer, M., Wang, S., O’Brien, K. D., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83475 · Cited by 178
Inflammation modulates human HDL composition and function in vivo
Moya, M. D. L. L., McGillicuddy, F. C., Hinkle, C. C., Byrne, M., Joshi, M. R., Nguyen, V., Tabita‐Martinez, J., Wolfe, M. L., Badellino, K. O., Pruscino, L., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.02.032 · Cited by 169
Effect of inflammation on HDL structure and function
Feingold, K. R., & Grünfeld, C. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000333 · Cited by 170
Self-citationCuaz‐Pérolin, C., Billiet, L., Baugé, E., Copin, C., Scott‐Algara, D., Genze, F., Büchele, B., Syrovets, T., Simmet, T., & Rouis, M. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.155606 · Cited by 171
Riwanto, M., & Landmesser, U. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r037762 · Cited by 174
Kim, M. S., Sweeney, T. R., Shigenaga, J. K., Chui, L. G., Moser, A., Grunfeld, C., & Feingold, K. R. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.007 · Cited by 168
Self-citationSorokin, A. V., Karathanasis, S. K., Yang, Z., Freeman, L. A., Kotani, K., & Remaley, A. T. (2020) · The FASEB Journal · doi:10.1096/fj.202001451 · Cited by 170
Rheumatoid Arthritis A Model of Systemic Inflammation Driving Atherosclerosis
Ku, I. A., Imboden, J. B., Hsue, P. Y., & Ganz, P. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0274 · Cited by 165
MicroRNAs in the interaction between host and bacterial pathogens
Maudet, C., Mano, M., & Eulálio, A. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.08.002 · Cited by 169
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Carbohydrates
Mesotten, D., Joosten, K., van Kempen, A. A. M. W., Verbruggen, S. C. A. T., Braegger, C., Bronský, J., Cai, W., Campoy, C., Carnielli, V. P., Darmaun, D., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.06.947 · Cited by 163
Kuula, H., Salo, T. A., Pirilä, E., Tuomainen, A. M., Jauhiainen, M., Uitto, V., Tjäderhane, L., Pussinen, P. J., & Sorsa, T. A. (2008) · Infection and Immunity · doi:10.1128/iai.00873-08 · Cited by 166
Kell, D. B., & Pretorius, E. (2015) · Integrative Biology · doi:10.1039/c5ib00158g · Cited by 169
Ng, P. C., Ang, I. L., Chiu, R. W. K., Li, K., Lam, H. S., Wong, R. P. O., Chui, K. M., Cheung, H. M., Ng, E. W. Y., Fok, T. F., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40196 · Cited by 160
Vascular endothelium dysfunction: a conservative target in metabolic disorders
Jamwal, S., & Sharma, S. (2018) · Inflammation Research · doi:10.1007/s00011-018-1129-8 · Cited by 161
Toll-like receptor 4 modulates skeletal muscle substrate metabolism
Frisard, M. I., McMillan, R. P., Marchand, J., Wahlberg, K. A., Wu, Y., Voelker, K. A., Heilbronn, L. K., Haynie, K. R., Muoio, B. M., Li, L., et al. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00307.2009 · Cited by 162
Levels, J. H. M., Marquart, J. A., Abraham, P. R., van den Ende, A., Molhuizen, H. O. F., van Deventer, S. J. H., & Meijers, J. C. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.4.2321-2326.2005 · Cited by 155
The Role of High-Density Lipoprotein in Inflammation
Navab, M., Anantharamaiah, G. M., & Fogelman, A. M. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.05.008 · Cited by 154
Zu, L., He, J., Jiang, H., Xu, C. B., Pu, S., & Xu, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807852200 · Cited by 155
Mitochondrial Dysfunction in Atherosclerosis
Peng, W., Cai, G., Xia, Y., Chen, J., Wu, P., Wang, Z., Li, G., & Wei, D. (2019) · DNA and Cell Biology · doi:10.1089/dna.2018.4552 · Cited by 155
A Review on Fucoidan Structure, Extraction Techniques, and Its Role as an Immunomodulatory Agent
Jayawardena, T. U., Nagahawatta, D. P., Fernando, I. P. S., Kim, Y.-T., Kim, J.-S., Kim, W.-S., Lee, J. S., & Jeon, Y.-J. (2022) · Marine Drugs · doi:10.3390/md20120755 · Cited by 149
Gabay, C., McInnes, I. B., Kavanaugh, A., Tuckwell, K., Klearman, M., Pulley, J., & Sattar, N. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207872 · Cited by 140
Zebeli, Q., & Ametaj, B. N. (2009) · Journal of Dairy Science · doi:10.3168/jds.2009-2178 · Cited by 150
Inflammation and Dyslipidemia Related to Risk of Spontaneous Preterm Birth
Catov, J. M., Bodnar, L. M., Ness, R. B., Barron, S. J., & Roberts, J. M. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm273 · Cited by 144
Apolipoproteins modulate the inflammatory response to lipopolysaccharide
Berbée, J. F. P., Havekes, L. M., & Rensen, P. C. N. (2005) · Journal of Endotoxin Research · doi:10.1179/096805105x35215 · Cited by 148
Physiological effects of modulating the interleukin-6 axis
Schett, G. A. (2018) · Rheumatology · doi:10.1093/rheumatology/kex513 · Cited by 148
Adipocyte, Adipose Tissue, and Infectious Disease
Desruisseaux, M. S., Nagajyothi, Trujillo, M. E., Tanowitz, H. B., & Scherer, P. E. (2006) · Infection and Immunity · doi:10.1128/iai.01455-06 · Cited by 143
The Role of Reactive Species on Innate Immunity
Andrés, C., Pérez de la Lastra, J., Juan, C., Plou, F., & Pérez-Lebeña, E. (2022) · Vaccines · doi:10.3390/vaccines10101735 · Cited by 142
Lymphotoxin ß Receptor–Dependent Control of Lipid Homeostasis
Lo, J. C., Wang, Y., Tumanov, A. V., Bamji, M., Yao, Z., Reardon, C. A., Getz, G. S., & Fu, Y. (2007) · Science · doi:10.1126/science.1137221 · Cited by 140
Maekawa, T., Takahashi, N., Tabeta, K., Aoki, Y., Miyashita, H., Miyauchi, S., Miyazawa, H., Nakajima, T. E., & Yamazaki, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020240 · Cited by 140
Plasma lipids and lipoproteins during pregnancy and related pregnancy outcomes
Emet, T., Üstüner, İ., Güven, S. G., Balık, G., Ural, Ü. M., Tekın, Y. B., Şentürk, Ş., Şahin, F. K., & Avşar, A. F. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-2750-y · Cited by 139
G2A and LPC: Regulatory functions in immunity
Kabarowski, J. H. S. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.04.007 · Cited by 144
Catapano, A. L., Pirillo, A., & Norata, G. D. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13805 · Cited by 138
Song, G., Li, M., Sang, H., Zhang, L., Li, X., Yao, S., Yu, Y., Zong, C., Xue, Y., & Qin, S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m036640 · Cited by 137
Periodontitis and cardiometabolic disorders: The role of lipopolysaccharide and endotoxemia
Pussinen, P. J., Kopra, E., Pietiäinen, M., Lehto, M. J., Zarić, S., Paju, S., & Salminen, A. (2022) · Periodontology 2000 · doi:10.1111/prd.12433 · Cited by 142
Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. M., Викторович, А. М., Alexandrova, L. M., Анциферова, А. А., Dm, A., Ахмеджанов, Н. М., Balanova, Y. А., et al. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2022-3235 · Cited by 197
HDL Remodeling During the Acute Phase Response
Jahangiri, A., de Beer, M. C., Noffsinger, V. P., Tannock, L. R., Ramaiah, C., Webb, N. R., van der Westhuyzen, D. R., & de Beer, F. C. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.178681 · Cited by 135
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
Chapman, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.003 · Cited by 138
Schmerler, D., Neugebauer, S., Ludewig, K., Bremer-Streck, S., Brunkhorst, F. M., & Kiehntopf, M. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p023309 · Cited by 134
Metadata
- Authors
- Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C.
- Affiliations
- Chulalongkorn University (TH)
- San Francisco VA Medical Center (US)
- Corresponding author
- Feingold, Kenneth R.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2004-07
- Volume
- 45
- Issue
- 7
- Pages
- 1169-1196
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2340325420
- Cited by
- 1,481
- References
- 388
- Citations by year
- 2026: 61 · 2025: 66 · 2024: 68 · 2023: 79 · 2022: 88 · 2021: 90 · 2020: 72 · 2019: 76 · 2018: 73 · 2017: 76 · 2016: 55 · 2015: 54 · 2014: 74 · 2013: 74 · 2012: 72
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK66999, R01DK066999, DK-49900)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- atherogenesis, acute phase response, infection, inflammation, lipid metabolism, lipoprotein metabolism, triglycerides, VLDL secretion, hepatic fatty acid synthesis, lipoprotein lipase, apolipoprotein E, hypercholesterolemia, hepatic cholesterol synthesis, LDL clearance, HDL metabolism, reverse cholesterol transport, LDL oxidation, ceramide, sphingomyelin, macrophage uptake, nuclear receptors, peroxisome proliferator-activated receptors, liver X receptor, farnesoid X receptor, retinoid X receptor, proatherogenic lipoproteins
- MeSH terms
- Animals, Humans, Immunity, Innate, Infections, Inflammation, Lipids, Lipoproteins, Receptors, Cytoplasmic and Nuclear, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review